Richard S. Makuch

Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine

Phillip R. Pittman, Richard S. Makuch, Joseph A. Mangiafico et al. · Vaccine · 1996 · 208 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience

Phillip R. Pittman, C.T. Liu, Timothy Lewis Cannon et al. · Vaccine · 1999 · 163 citations

Veterinary Medicine, Immunology, Infectious Diseases +12

Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans

Phillip R. Pittman, David J. McClain, Xiaofei Quinn et al. · Vaccine · 2015 · 43 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

The immunogenicity in humans of a botulinum type F vaccine

Vicki A. Montgomery, Richard S. Makuch, J. Brown et al. · Vaccine · 1999 · 19 citations

Veterinary Medicine, Immunology, Immunization +11

Classification of cell lines derived from undifferentiated lymphomas according to their expression of complement and Epstein-Barr virus receptors: Implications for the relationship between African and American Burkitt's lymphoma

C B Freeman, Ian Magrath, David C. Benjamin et al. · Clinical Immunology and Immunopathology · 1982 · 10 citations

Medicine, Oncology, Pathology +13